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Background. There are not enough large epidemiologic
population-based studies of biopsy-proven nephropathies with
detailed clinicopathologic correlations.
Methods. The Glomerulonephritis Registry of the Spanish
Society of Nephrology has obtained data from 9378 cases with
native biopsy-proven renal diseases and well-known clinical
syndrome between 1994 and 2001, investigating clinicopatho-
logic correlations. Patients were divided in three groups accord-
ing to age: children (<15 years old), adults (15 to 65 years), and
elderly (>65 years).
Results. The most common clinical syndrome at any age
is nephrotic syndrome (35.5%), followed by asymptomatic
urinary abnormalities (25.9%), acute renal failure (12.9%),
chronic renal failure (12.1%), nephritic syndrome (4.5%),
macroscopic haematuria (4.5%), and arterial hypertension
(3.0%). A male predominance is observed at any age (3:2).
The frequencies of histologic findings are statistically different
in all syndromes according to age. Minimal change disease is
the most frequent finding in children with nephrotic syndrome
(39.5%), whereas in adults and elderly, membranous nephropa-
thy is the most prevalent (24.2% and 28.0%, respectively). Ig A
nephropathy (IgAN) is the most frequent glomerulonephritis
in patients with asymptomatic urinary abnormalities at any age.
Acute renal failure is an important cause for performing a kid-
ney biopsy in elderly and vasculitis is the main histologic finding.
The clinical manifestations of focal segmental glomerulosclero-
sis, non-IgA mesangial nephropathy, lupus nephritis, vasculitis,
and nephroangiosclerosis are statistically different according to
age.
Conclusion. The findings of clinicopathologic correlations
obtained from the Spanish Registry of Glomerulonephritis on
native biopsy-proven renal diseases add valuable information
to previous reports and it can be the initial step for follow-up
and prospective studies.
The knowledge of the epidemiology of biopsied re-
nal diseases provides useful information in clinical prac-
tice. However, this information must be completed with
1Participants and affiliations in Appendix 1.
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clinicopathologic correlations. There are several epi-
demiologic population-based studies of biopsy-proven
nephropathies with detailed clinicopathologic correla-
tions that could be different according to the country
analyzed [1–9]. In a previous paper, we have described
the frequency of native biopsy-proven renal diseases in
Spain during 1994 to 1999 [10].
The aim of this study is to provide data of clinical mani-
festations of biopsy-proven native renal diseases in Spain
during 1994 to 2001, to identify the most frequent clinical
syndromes and the manifestations of each renal disease.
METHODS
We analyzed the clinicopathologic correlations of biop-
sied renal diseases during the years 1994 to 2001 with the
data obtained from the Spanish Registry of Glomeru-
lonephritis [10]. We recorded one questionnaire for
each patient with the following variables: name; hospi-
tal; date of birth; gender; blood pressure; serum creati-
nine (mg/dL); creatinine clearance (mL/min); proteinuria
(g/day); urinary sediment: normal, hematuria, leukocy-
turia, casts; known evolution time until renal biopsy
in years; main clinical syndrome: nephrotic, nephritic,
asymptomatic urinary abnormalities (AUA), arterial hy-
pertension, acute renal failure (ARF), chronic renal fail-
ure (CRF), and macroscopic hematuria; study methods:
optic microscope, immunofluorescence, electron micro-
scope, and number of glomeruli obtained.
Primary glomerulonephritis (GN) has been classified
into eight groups: minimal change disease (MCD), fo-
cal and segmental glomerulosclerosis (FSGS), prolif-
erative endocapillary GN, crescentic GN (presence of
crescents in more than 50% of glomeruli) type I, II
and III according to standard classification (CRESGN)
[11], membranoproliferative type I and II GN (MPGN),
membranous nephropathy (MN), Ig A nephropathy
(IgAN), mesangioproliferative non-IgAN (non-IgAN).
Secondary GN has been classified into another eight
groups [fibrillary, lupus nephritis (LN), collagenosis (scle-
roderma and other connective tissue disease not included
in other diagnosis), vasculitis (VAS), Goodpasture’s
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Table 1. Percentages of predominate renal syndromes according to age and gender
>15 yearsa ≥15 to 65 yearsb ≤ 65 yearsc Whole populationd
N = 939 N = 6266 N = 2173 N = 9378
% % % %
Male Female Male Female Male Female Male Female
N = 545 N = 394 N = 3818 N = 2448 N = 1305 N = 868 N = 5668 N = 3710
Nephrotic 42.0 35.5 32.5 37.7 36.6 36.2 34.4 37.2
Nephritic 12.8 10.7 3.7 3.5 4.6 4.7 4.8 4.6
Urinary abnormalities 20.7 34.5 28.9 33.5 12.1 10.9 24.3 28.3
Hypertension 0.4 0.8 4.7 2.7 1.8 2.3 3.6 2.4
Acute renal failure 3.9 6.1 10.7 9.4 25.4 28.9 13.4 13.6
Chronic renal failure 2.6 2.5 14.4 9.4 18.9 16.2 14.2 10.2
Macroscopic hematuria 17.6 9.9 5.2 3.8 0.7 0.7 5.3 3.7
aP = 0.000 <15 years (male vs. female); bP = 0.000 15 to 65 years (male vs. female); cP = 0.000 ≥65 years (male vs. female); dP = <0.0005 whole group (male vs. female).
syndrome, cryoglobulinemic GN, amyloidosis (AMYL),
and light-chain nephropathy]. CRESGN type III or
pauci-immune rapidly progressive GN were included in
the VAS group. Noninflammatory renal pathology has
also been classified into eight groups [diabetic nephropa-
thy, nephroangiosclerosis (NA) (benign and malignant),
atheroembolic disease, acute tubular necrosis, myeloma
kidney, thrombotic microangiopathy, acute tubulointer-
stitial nephropathy (ATIN) and chronic tubulointerstitial
nephropathy (CTIN)]. The remaining causes have been
classified into three groups [unclassified nephropathies
(UN), renal sclerosis (RSC), and other miscellaneous
pathologies (MIS)]. Biopsies of transplant kidneys have
not been considered.
Patients younger than 15 years old were classified as
children, those between 15 and 65 years as adults and
those older than 65 years were classified as elderly people.
Nephrotic syndrome was defined as proteinuria greater
than 3.5/g/day/1.73 m2 and serum albumin less than
2.5 g/dL. Nephritic syndrome was defined as hematuria,
hypertension, oliguria, edema, and reduced glomerular
filtration rate (GFR). Urinary abnormalities included
persistent nonnephrotic proteinuria and/or microscopic
hematuria. Hypertension was considered when blood
pressure was higher than 140/90 mm Hg. ARF was de-
fined as a rapid deterioration of GFR, while CRF was con-
sidered when serum creatinine levels were persistently
above 1.5 mg/dL.
Statistical analysis
Each year, data were stored on a database file (MS Ac-
cess 2000). All the statistics were done by means of the
statistical package SPSS for Windows 10.0.6 (SPSS Sys-
tat Inc, Chicago, IL, USA). Data were tested for normal
distribution with the Kolmogorov–Smirnov test. The val-
ues are expressed as medians when the parameters did
not fit into a normal (Gaussian) distribution. Chi-square
and Fisher’s tests are used to compare qualitative vari-
ables. A P value of less than 0.05 (by two-tailed testing)
is considered to indicate statistical significance.
RESULTS
Records from 9378 renal biopsies, obtained from 93
renal units (81 adult and 12 pediatric units) were studied
during 1994 to 2001. We could analyze 8722 cases through
completing the questionnaire with the main clinical syn-
drome and its histopathologic findings.
Clinical syndromes and histopathologic findings
The distribution of clinical syndromes according to age
and gender is included in Table 1. The most common
clinical syndrome at any age is nephrotic syndrome
(35.5% in the whole group), followed by asymptomatic
urinary abnormalities (25.9%), ARF (12.9%), CRF
(12.1%), nephritic syndrome (4.5%), macroscopic hema-
turia (4.5%), and arterial hypertension (3.0%). A male
predominance is observed at any age (male/female ratio
of 3:2).
Table 2 shows the causes of nephrotic syndrome with
statistically significant differences (P < 0.0005, v 2 test).
In children, MCD prevails whereas in adults and elderly
patients, MN does.
Acute nephritic syndrome also had statistically signifi-
cant differences (P < 0.0005, v 2 test). IgAN (31.0%) and
endocapillary GN (19.0%) are the most frequent patholo-
gies in children; LN (19.4%) and IgAN (14.8%) in adults;
and VAS (40.4%) and CRESGN (17.0%) in the elderly.
Table 3 indicates the causes of AUA. IgAN and MCD
prevail in children; IgAN and LN prevail in adults and
only IgAN does in the elderly (P < 0.0005, v 2 test).
Table 4 shows the etiologies of ARF. In children
(only 25 cases) thrombotic microangiopathy was the most
prevalent finding, whereas VAS was in adults and in the
elderly (P < 0.0005, v 2 test).
CRF had statistically significant differences (P <
0.0005, v 2 test). In children (only 22 cases) chronic tubu-
lointerstitial nephritis (22.7%) and MIS (29.4%) prevail,
IgAN (19.4%) and FSGS (14.4%) in adults (N = 71) and
NA (18.6%) and VAS (10.6%) in the elderly (N = 264).
Macroscopic hematuria had less significant differences
(P = 0.04, v 2 test) with a high prevalence of IgAN at any
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Table 2. Nephrotic syndrome: Frequency of different forms of
biopsy-proven nephropathies
<15 years ≥15 to 65 years ≥65 years
N = 263 N = 2019 N = 725
Histopathologic diagnosis % % %
MCD 39.5 15.7 13.2
FSGS 26.6 12.3 9.7
Endocapillary GN 1.1 0.2 0.6
CRESGN (I + II) 0 0.4 1.2
MPGN (I + II) 3.8 6.9 7.2
MN 4.9 24.2 28.0
IgAN 3.8 5.9 2.3
Non-IgAGN 8.4 3.9 2.6
Fibrillary GN 0 0.1 0.6
LN 6.5 13.6 1.4
Collagenosis 0 0.1 0.1
VAS 1.1 0.8 2.2
Goodpasture 0 0.1 0
Cryoglobulinemic GN 0 0.3 1.1
AMYL (I + II) 0.9 5.7 17.2
Light chain GN 0 0.2 0.7
Diabetic nephropathy 0 3.5 5.0
NA 0 1.3 1.7
Other noninflamatory 0 0.8 1.1
diseases
UN 0 2.1 1.9
RSC 0.5 0.8 1.0
MIS 2.7 0.9 1.2
Abbreviations are: AMYL, amyloidosis; CRESGN, crescentic glomeru-
lonephritis; FSGS, focal and segmental glomerulosclerosis; GN, glomeru-
lonephritis; IgAN, IgA nephropathy; LN, lupus nephropathy; MCD, minimal
change disease; NA, nephroangiosclerosis; MIS, miscellaneous; MN, membra-
nous glomerulonephritis; MPGN, membranoproliferative glomerulonephritis;
UN, unclassified nephropathy; VAS: vasculitis; RSC, renal sclerosis.
P < 0.0005 (v 2).
age (children 66.3%, adults 58.3%, and elderly 42.9%),
followed by MIS (18.1% in children and 12.5% in adults)
and VAS in elderly (28.6%).
Histopathologic findings and clinical manifestations
The frequencies of the main clinical syndromes of sev-
eral renal pathologies are statistically different according
to age.
MCD were mainly manifested in all age groups as
nephrotic syndrome (children 78.2%, adults 79.0%, and
elderly 88.9%), followed by AUA (children 18.8%, adults
17.6%, and elderly 5.6%). The frequency of these clinical
syndromes shows no statistical differences, v 2 test). No
significant differences were also found between genders.
FSGS in children was also mainly manifested as
nephrotic syndrome (84.3%), followed by AUA (9.8%);
in adults was mainly manifested as nephrotic syndrome
(42.2%), followed by AUA (35.1%), and in the elderly,
the nephrotic syndrome was the most frequent mani-
festation (59.8%) followed by CRF (16.2%) and AUA
(16.2%). The frequency of these clinical syndromes shows
statistical differences (P < 0.0005, v 2 test), but with no
differences according to gender.
CRESGN (that excluded type III extracapillary GN)
is very infrequent in children (only six cases, three with
nephritic syndrome and three with ARF); in adults, were
Table 3. Asymptomatic urinary abnormalities: Frequency of
different forms of biopsy-proven nephropathies
<15 years ≥15–65 years ≥65 years
N = 122 N = 1549 N = 195
Histopathologic diagnosis % % %
MCD 18.9 4.1 2.9
FSGS 7.6 12.0 9.3
Endocapillary GN 2.3 0.5 0
CRESGN (I + II) 0 0.1 3.4
MPGN (I + II) 1.5 2.9 2.4
MN 1.5 3.7 6.3
IgAN 22.0 27.4 16.6
Non-IgAGN 15.9 6.3 2.0
Fibrillary GN 0 0.2 1.5
LN 10.6 16.2 3.4
Collagenosis 0 0.3 0
VAS 5.3 2.2 11.7
Goodpasture 0 0.1 0
Cryoglobulinemic GN 0 0.2 1.5
AMYL (I + II) 0.8 1.6 3.4
Light chain GN 0 0.2 1.5
Diabetic nephropathy 0 1.9 7.8
NA 0 5.3 13.2
Other noninflamatory diseases 0.8 2.8 3.9
UN 3.8 4.3 4.4
RSC 0 1.1 1.5
MIS 8.3 6.6 3.4
Abbreviations are: AMYL, amyloidosis; CRESGN, crescentic glomeru-
lonephritis; FSGS, focal and segmental glomerulosclerosis; GN, glomeru-
lonephritis; IgAN, IgA nephropathy; LN, lupus nephropathy; MCD, minimal
change disease; NA, nephroangiosclerosis; MIS, miscellaneous; MN, membra-
nous glomerulonephritis; MPGN, membranoproliferative glomerulonephritis;
Non-IgAN, non-IgA mesangioproliferative glomerulonephritis; UN, unclassified
nephropathy; VAS: vasculitis; RSC, renal sclerosis.
P < 0.0005 (v 2).
mainly manifested as ARF (59.4%) followed by nephritic
syndrome (17.0%); in the elderly, ARF was the most
frequent manifestation (64.3%) followed by nephritic
syndrome (16.3%). The frequency of these clinical syn-
dromes has no statistical differences according to age and
gender (v 2 test).
MPGN manifests in more than half of the cases at
any age with nephrotic syndrome (children 66.7%, adults
54.6%, and elderly 61.2%), followed by AUA in children
and adults (13.3% and 19.6%, respectively) and ARF in
the elderly (12.9%). The frequency of these clinical syn-
dromes shows no statistical differences (v 2 test).
MN is mainly manifested as nephrotic syndrome in all
age groups (Table 5).
IgAN has a clearly different manifestations for each
age group. In children, macroscopic hematuria (50.5%)
was the most frequent clinical syndrome whereas in adults
and in the elderly, AUA (46.9% and 31.5%, respectively)
(Table 6).
Non-IgA GN in children was mainly manifested as
nephrotic syndrome (42.3%), followed by AUA (40.4%);
in adults, AUA (44.9%), followed by nephrotic syndrome,
(32.4%) were the most frequent manifestations, whereas
in elderly, nephrotic syndrome (44.2%) followed by CRF
(23.3%). The frequency of these clinical syndromes shows
statistical differences, P < 0.0005, v 2 test).
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Table 4. Acute renal failure: Frequency of different forms of
biopsy-proven nephropathies
<15 years ≥15 to 65 years ≥65 years
N = 25 N = 589 N = 547
Histopathologic diagnosis % % %
MCD 4.0 0.3 0.7
FSGS 0 1.5 1.5
Endocapillary GN 8.0 2.1 2.3
CRESGN (I + II) 12.0 10.3 11.5
MPGN (I + II) 0 2.9 2.0
MN 0 0.5 0
IgAN 4.0 11.3 5.5
Non-IgAGN 4.0 1.8 0.9
Fibrillary GN 0 0.3 0
LN 4.0 5.5 0.9
Collagenosis 0 0.5 0.2
VAS 4.0 20.2 36.9
Goodpasture 0 2.6 1.5
Cryoglobulinemic GN 0 1.1 0.7
AMYL (I + II) 0 2.0 1.8
Light chain GN 0 0.2 0.7
Diabetic nephropathy 0 1.6 1.5
NA 0 3.9 2.7
Thrombotic microangiopathy 24.0 4.2 1.5
Atheroembolic disease 0 0.3 1.3
Acute tubular necrosis 4.0 3.9 6.8
Myeloma kidney 0 2.4 4.4
ATIN 12.0 11.3 7.3
CTIN 0 1.8 1.8
UN 4.0 2.3 2.0
RSC 4.0 1.5 2.0
MIS 12.0 3.6 1.3
Abbreviations are: AMYL, amyloidosis; ATIN, acute tubulointerstitial
nephritis; CRESGN, crescentic glomerulonephritis; CTIN, chronic tubu-
lointerstitial nephritis; FSGS, focal and segmental glomerulosclerosis; GN,
glomerulonephritis; IgAN, IgA nephropathy; LN, lupus nephropathy; NA,
nephroangiosclerosis; MCD, minimal change disease; MIS, miscellaneous; MN,
membranous glomerulonephritis; MPGN, membranoproliferative glomeru-
lonephritis; Non-IgAN, non-IgA mesangioproliferative glomerulonephritis; UN,
unclassified nephropathy; VAS: vasculitis; RSC, renal sclerosis.
P < 0.0005 (v 2).
Table 5. Membranous glomerulonephritis: Frequency of different
clinical syndromes
<15 years ≥15 to 65 years ≥65 years
N = 15 N = 580 N = 223
Main clinical syndrome % % %
Nephrotic 86.7 86.0 91.0
Nephritic — 0.2 0.4
Asymptomatic urinary 13.3 11.2 5.8
abnormalities
Hypertension — 0.2 —
Acute renal failure — 0.5 —
Chronic renal failure — 1.6 2.7
Macroscopic hematuria — 0.3 —
P = NS (v 2).
LN is the most frequent secondary GN in children
and adults (6.5% and 11.7% of all patients, respectively),
whereas LN was only found in 1.4% of the elderly.
Nephrotic syndrome is present in 44.7%, 41.8%, and
37.0% in children, in adults and in elderly respectively.
Only in adults, AUA was slightly more frequent (42.1%)
than nephrotic syndrome (Table 7).
VAS is rare in children (only 16 cases) and is mainly
manifested as AUA (43.8%). In adults and elderly, ARF
Table 6. IgA nephropathy: Frequencies of different clinical
syndromes
<15 years ≥15 to 65 years ≥65 years
N = 109 N = 1023 N = 108
Main clinical syndrome % % %
Nephrotic 9.2 11.8 15.7
Nephritic 11.9 3.1 5.6
Asymptomastic urinary 26.6 46.9 31.5
abnormalities
Hypertension — 3.4 —
Acute renal failure 0.9 6.7 27.8
Chronic renal failure 0.9 12.9 13.9
Macroscopic hematuria 50.5 15.1 5.6
P < 0.0005 (v 2).
Table 7. Lupus nephropathy: Frequency of different clinical
syndromes
<15 years ≥15 to 65 years ≥65 years
N = 38 N = 672 N = 27
Main clinical syndrome % % %
Nephrotic 44.7 41.8 37.0
Nephritic 10.5 6.3 7.4
Asymptomatic urinary 36.8 42.1 5.91
abnormalities
Hypertension 2.6 0.6 —
Acute renal failure 2.6 5.1 18.5
Chronic renal failure 2.6 3.6 11.1
Macroscopic hematuria — 0.6 —
P = 0.011 (v 2).
is the most frequent clinical syndrome (52.3% and 64.7%,
respectively).
AMYL is very infrequent in children (only three
cases, two of them with nephrotic syndrome); in adults,
nephrotic syndrome was the most common clinical syn-
drome (65.9%) followed by AUA (15.6%); in elderly, the
nephrotic syndrome was also the most frequent mani-
festation (78.1%) followed by CRF (10.6%). The fre-
quency of these clinical syndromes shows no statistical
differences between the last groups (v 2 test).
NA was absent in children; in adults, was mainly
manifested as arterial hypertension (28.0%) and AUA
(28.4%), whereas in the elderly, it manifests as CRF
(43.0%) followed by AUA (23.7%), with statistically sig-
nificant differences (P < 0.0005).
Diabetic nephropathy was also absent in children. In
adults, it was mainly manifested as nephrotic syndrome
(50.0%), followed by AUA (22.9%) and CRF (16.7%).
In the elderly, the nephrotic syndrome was the most fre-
quent manifestation (41.4%) followed by CRF and AUA
(29.9% and 18.4%, respectively). The frequency of these
clinical syndromes shows no statistical differences.
DISCUSSION
In this study, we complete the analysis of renal diseases
with the clinicopathologic correlations obtained from the
data of the Spanish Registry of Glomerulonephritis that
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Table 8. Nephrotic syndrome: Main pathologies involved (%)
Italy Denmark Japan Korea United Arab
Spain [1] [6] [7] [9] Emerits [19]
MCD 17.1 12 23.5 37.7 59.4 26.2
FSGS 14.1 12.3 8 9 11.1 15.4
MN 22.9 32.9 22.4 23.3 15.9 28.3
IgAN 4.5 2.4 17.5 19.2 3.3 3.2
MPGN 6.5 4.6 9.9 6.8
Abbreviations are: FSGS, focal and segmental glomerulosclerosis; IgAN,
IgA nephropathy; MCD, minimal change disease; MN, membranous glomeru-
lonephritis; MPGN, membranoproliferative glomerulonephritis.
has been previously reported [10]. Although several bi-
ases will attenuate the value of the study, we obtained
representative findings about clinical manifestations of
biopsied renal diseases in our country.
A male predominance of the main clinical syndromes
has been observed in the whole population, as occurs in
the majority of biopsied renal pathologies [10]. In our
results, it is particularly interesting that the renal biopsy
findings of each clinical syndrome are different according
to age. The nephrotic syndrome is the main indication for
kidney biopsy at any age in our registry. It is in contrast
with the results in other countries, as Italy, where AUA
is the main indication to perform the renal biopsy [1]. In
the whole population, the first causes of nephrotic syn-
drome are MN, MCD, and FSGS. These data are similar
to those of western countries and differ from the data
published in other countries (Table 8), probably due to
different policies in the indication of renal biopsies. As
in other European countries, we have not observed any
increase in the annual incidence of FSGS as a cause of
nephrotic syndrome, as it has been shown in other re-
ports, mainly from the United States and Singapore [12,
13]. In fact, three studies in the United States have dis-
closed that since 1995, FSGS is the most common cause of
adult nephrotic syndrome [13–15]. Moreover, racial dif-
ferences, nutritional behaviors and environmental factors
may have been implicated in this difference in our popu-
lation.
As was expected, MCD is the main cause of nephrotic
syndrome in children (39.5%), followed by FSGS
(26.6%). This is in concordance with most of the studies
published. In the report of the Italian National Registry
of renal biopsies in children [2], the nephrotic syndrome
was due mainly to MCD (34.5%) and FSGS (16.9%). In
the large series from Korea [9], most of the nephrotic syn-
dromes in 426 children were due to MCD (71.4%) and
FSGS (12.2%). In the elderly, the nephrotic syndrome is
mainly due to MN and AMYL, whereas MCD and FSGS
are less prevalent than in children or adults. Although
there are few data in the literature about the distribution
of histologic lesions in elderly patients with nephrotic syn-
drome, the experience of some short series is coincident
with our data (Table 9).
Acute nephritic syndrome also shows different biopsy
findings in each age group. In our study, in children, it is
mainly caused by IgAN and endocapillary GN that ac-
counts for more than half of the biopsies. In adults with
nephritic syndrome, the main nephropathies are LN and
VAS. However, in elderly patients, most cases are due to
VAS and CRESGN as was expected. The only registries
that provide information about renal biopsies in nephritic
syndrome are those from Italy [1] and Japan [7], whose
findings, unclassified by age, are quite similar to ours.
Asymptomatic urinary abnormalities in adults and the
elderly are mainly caused by IgAN. In children the main
nephropathies are MCD and also IgAN. These data in
children are quite different to those reported by the Ital-
ian registry, in which there were 135 cases (IgAN 30.4%,
Scholein Henoch 23%, and MPGN 5.2%) [1] and in a
Japanese series in 54 patients (IgAN 54%, non-IgA GN
29%, MN 5.5%) [16]. The reasons for these differences
are not clear enough, but it could be reflecting a more
conservative approach toward renal biopsies in children
in our country. Whether the steroid-sensitive nephritic
syndrome in children is biopsied or not can be influenc-
ing the differences in frequencies.
In our study, biopsied ARF is caused in adults and el-
derly patients predominantly by VAS and crescentic GN.
These data are similar to the survey of the Italian registry
[1] with 34.1% frequency of vasculitis and crescentic GN
in 1059 renal biopsies of patients with ARF. Similar re-
sults have been also reported in Baltimore [17], with 259
renal biopsies of adults older than 60 years with ARF,
showing that crescentic GN represented 35.2% of the
diagnoses. All these data emphasize the value of renal
biopsy in the management of ARF of uncertain origin,
irrespective of the age of the patient. Accurate diagnosis
of the renal lesion is of great importance in promptly di-
recting an appropriate treatment, especially in vasculitis
and crescentic GN.
CRF as the clinical syndrome that justifies the renal
biopsy is mainly caused by IgAN and FSGS in adults,
whereas NA and VAS are the most common causes in
the elderly. These data confirm that IgAN is the primary
cause of end-stage renal disease secondary to idiopathic
GN. Similar data have been published by other series [1,
4]. However, the indications to perform renal biopsies in
these patients could be different according to kidney size,
comorbidity and the renal biopsy policy in each center
[18].
Conversely, the clinical manifestations of the biopsied
renal diseases show significant differences depending on
the age at presentation. In our experience, there are six
renal pathologies (FSGS, IgA and non-IgA mesangial
nephropathies, LN, VAS, and nephroangiosclerosis) that
show a clinical picture statistically different according to
age. In fact, this is one of the first reports to analyze the
clinical manifestations of individual nephropathies in a
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Table 9. Nephrotic syndrome in the elderly: Main pathologies involved (%)
Spain Cameron [20] Davidson [21] Colombo [22] Modesto [23] Moorthy [24] Vendemia [25]
N = 725 N = 164 N = 317 N = 107 N = 92 N = 33 N = 569
MN 28.0 38 37 48 35 39 13.4
MCD 13.2 21 11 2 14 27 2.4
FSGS 9.7 2 4 15 0 4 2.3
MPGN 7.2 4 6 5 11 6 2.9
AMYL 17.2 12 11 10 20 9
Diabetic nephropathy 5.0 4 4 5 1
VAS 2.2 2 1
Abbreviations are: AMYL, amyloidosis; FSGS, focal and segmental glomerulosclerosis; MCD, minimal change disease; MN, membranous glomerulonephritis;
MPGN, membranoproliferative glomerulonephritis; VAS: vasculitis.
large series of renal biopsies in an unselected population
according to age. Recently, the Italian Registry of Renal
Biopsies found that several primary GN occur more fre-
quently in the elderly than in the adult [25]; however, in
our experience this finding was not found [10].
The clinical manifestations of FSGS in our data are par-
ticularly interesting. Whereas in all ages it is manifested
mainly by nephrotic syndrome, in adults this syndrome is
less frequent; indeed, AUA in adults with FSGS is dou-
ble and threefold more common compared to elderly pa-
tients and children, respectively. These findings suggest
that FSGS in adults could be an unspecific morphologic
lesion with many unknown aetiologies other than idio-
pathic nephrotic syndrome (viral infections, hyperfiltra-
tion, obesity, and undiagnosed metabolic or congenital
renal diseases). Probably the use of ultrastrucural and
molecular studies could help to clarify this disease [10,
13].
MPGN is manifested in half of the cases and at any age
by nephrotic syndrome. These findings are comparable
with those obtained in the large series of MPGN pub-
lished in the 1970s and 1980s. In Spain, a sharp significant
decline in the frequency of MPGN was observed during
the 1980s and only a slight trend to decrease has been
found more recently [26].
IgAN has clear different manifestations within each
age group. In children, macroscopic hematuria predom-
inates, but in adults and elderly patients, AUA does.
Obviously, these results represent a more conservative
approach in children and not different clinical manifes-
tations, with fewer biopsies performed purely because of
persistent microscopic hematuria. Non-IgA GN shows
also a particularly clinical manifestations; probably most
of the forms in children and the elderly are variants of
idiopathic nephrotic syndrome but in adults could be an
undiagnosed IgAN or unknown renal diseases.
LN is the only histologic pathology which is more
prevalent in females than in males, as has been reported
in other series [5, 6]. In our experience, LN is very infre-
quent in children and elderly people. In both age groups,
nephrotic syndrome is the main clinical syndrome. How-
ever, in adults the first manifestation is AUA followed by
nephrotic syndrome. This finding could fortunately reflect
an early approach to perform renal biopsy in young lupus
patients with early manifestations of renal complications.
VAS (that includes type III extracapillary GN) is man-
ifested as AUA or nephritic syndrome in children. How-
ever, in adults and elderly ARF significantly prevails,
emphasizing that most of the rapidly progressive GN in
these groups were caused by VAS.
Biopsied NA shows in adults the expected finding that
is manifested by hypertension and AUA. However, in
elderly patients, CRF and AUA are the main manifesta-
tions. These findings suggest that this vascular alteration
is not always a manifestation closely linked to arterial
hypertension.
Finally, in our experience, biopsied ND is manifested
in adults and elderly patients by nephrotic syndrome. Al-
though in our registry, the indication of renal biopsy is not
asked we assume that the clinical picture was atypical.
The Spanish Registry of Glomerulonephritis is one of
the largest registries in the world and the findings of clin-
icopathologic correlations obtained from it add valuable
clinical information to previous reports in this field. Its
design can stablish a basis for follow-up and prospective
studies.
APPENDIX 1. PARTICIPATING RENAL UNITS
A´lava (J.C. Anitu´a, R. Ruiz de Gauna, F. Viana); Albacete (E. Gal-
lego, E. Olivas); Alicante (M.D. Arenas, E. Bosque, J. Cabezuelo, C. del
Pozo, R. Enrı´quez, M.T Gil, C. Gonza´lez, J. Olivares, M. Perdiguero, A.
Reyes, F. Rivera); Almeria (M. Garcı´a Valverde); Asturias (R. A´lvarez,
J. A´lvarez Grande, J. Baltar, S. Ma´laga, F. Ortega); A´vila (J.C. Chaco´n,
A. Hidalgo, J. Martı´n); Badajoz (M. Arroba, R. Robles); Baleares (J.
Bernabeu, M. del Rı´o, J. Gasco´, P. Losada, X. Molina, A. Morey, C.
Piza, P. Serrano, D. Tura, X. Vidal); Barcelona (J. Balları´n, F. Calero, L.
Carreras, L. Garcı´a, M. Mir, R. Poveda, A. Rodrı´guez Jornet, A. Serra);
Burgos (P. Abaigar, G. Torres); Ca´ceres (A. Covarsı´, R. Novillo); Ca´diz
(M.L. Alcala´, M. Almaraz, E. Ferna´ndez Ruiz, T. Garcı´a, M. Ramos,
M. Ribero, G. Salgado, G. Velasco); Castello´n (X. Calvo, J. Herna´ndez
Jaras, F. Maduell, V. Navarro); Co´rdoba (F. Go´mez Carrasco); Corun˜a,
A (M. Adeva, D. Gu¨imil, X.M. Lens, D. Sa´nchez Guisande, F. Valde´s,
E. Va´zquez Martull); Cuenca (B. Rinco´n, F. Tornero, J. Uso´n); Girona
(X. Bromsons); Granada (C. Asensio, F.J. Gonza´lez, M. Gonza´lez, J.M.
Osorio, X. Peinado); Guadalajara (M. Sa´nchez, F. Garcı´a Martı´n);
Guipu´zcoa (A. Argoitia, J.J. Ruiz Laiglesia); Huelva (X. Onaindı´a, C.
Sua´rez, J. Gonza´lez); Huesca (X. Gonza´n˜ez, C. Laviades, J.M. Logron˜o,
X. Virto); Jae´n (J. Borrego, F. Ferna´ndez Montero, P. Serrano); Las Pal-
mas (M.D. Checa, N. Esparza, A. Moreno, C. Plaza, S. Surı´a); Leo´n (M.
Granda); Lleida (M.L. Amoedo, J. Mardares, J. Zonas, E. Ferna´ndez);
904 Rivera et al: Clinicopathologic correlations of renalpathology in Spain
Lugo (M. Ranero); Madrid (V. Barrio, C. Bernis, S. Casado, F. Dapena,
R. Delgado, C. Dı´az, V. Giner, F. Go´mez Campdera´, G. Go´nza´lez
Parra, E. Herna´ndez, J.M. Lo´pez Go´mez, A. Luque, M.J. Martı´nez,
J. Martı´nez-Ara, A. Me´ndez, A. Pen˜a, R. Pe´rez Garcı´a, M. Praga, J.
Portole´s, M. Va´zquez, G. Va´zquez, A. Vigil); Ma´laga (M.J. Alfe´rez, A.
Bueno, M.A. de Frutos, G. Martı´n-Reyes, J.M. Martı´nez, M. Milla´n, X.
Pen˜a, A. Valera); Murcia (S. Alegrı´a, A.J. Andreu, E. Lo´pez Guille´n, F.
Pe´rez Silva, R. Rodado); Ourense (E. Armada, J. Esteban, A. Otero, C.
Pe´rez); Palencia (E. Herna´ndez Garcı´a, J.M. Monfa´, F. Sousa); Ponteve-
dra (R. Alonso, L. Gonza´lez, B. Pazos, E. Pela´ez, A. Pereira, J. Sobrado);
Rioja (M. Sierra); Salamanca (J.M. Tabernero); Segovia (J. A´lvarez-
Ude, M. Ferna´ndez Reyes); Sevilla (J. Ferna´ndez, M.J. Gutie´rrez, C.
Jarava, J. Martı´n Govantes, A. Sa´nchez); Soria (M. Asensio); Tarrag-
ona (J.A. Oliver); Tenerife (E. de Bonis, V. Garcı´a Nieto, J.J. Garcı´a
Pe´rez, A. Herna´ndez, D. Herna´ndez Marrero, B. Martı´n, A. Rivero,
A. Rodrı´guez); Teruel (X. Bedisa, J.J. Belvis, X. Bergasa); Toledo (J.J.
Ahijado, J. Sierra); Valencia (X. Abarca, E. Alcoy, J.M. Escobedo, J.L.
Go´rriz, L. Pallardo´, A. Pe´rez Garcı´a, J.S. Pons, J.M. Simo´n, I. Zamora);
Valladolid (J. Briso, J. Bustamante, A. de Paula, A. Molina, M.E. Pla-
garo, A. Rodrigo); Vizcaya (F. Gainza, I. Martı´nez, J. Montenegro, R.J.
Ortiz Vigo´n, R. Saracho, A. Vallo, S. Za´rraga); Zamora (J. Deira, J.
Grande); and Zaragoza (J.A. Gutie´rrez Colo´n, M. Heras, C. Loris, J.
Uso´n).
Reprint requests to Dr. Francisco Rivera Herna´ndez, Servicio de Ne-




1. SCHENA FP, AND THE ITALIAN GROUP OF RENAL IMMUNOPATHOLOGY:
Survey of the Italian Registry of Renal Biopsies. Frequency of the
renal diseases for 7 consecutive years. Nephrol Dial Transplant
12:418–426, 1997
2. COPPO R, GIANOGLIO B, PORCELLINI MG, MARINGHINI S: Frequency
of renal diseases and clinical indications for renal biopsy in children
(report of the Italian National Registry of Renal Biopsies in Chil-
dren). Group of Renal Immunopathology of the Italian Society of
Paediatric Nephrology and Group of Renal Immunopathology of
the Italian Society of Nephrology. Nephrol Dial Transplant 13:293–
297, 1998
3. JOHNSTON PA, BROWN JS, BRAUMHOLTZ DA, DAVISON AM: Clinico-
pathological correlations and long-term follow-up of 253 United
Kingdom patients with IgA nephropathy. A report from the MRC
Glomerulonephritis Registry. Q J Med 84:619–627, 1992
4. SIMON P, RAMEE MP, AUTULY V, et al: Epidemiology of primary
glomerular diseases in a French region. Variations according to pe-
riod and age. Kidney Int 46:1192–1198, 1994
5. BRIGANTI EM, DOWLING J, FINLAY M, et al: The incidence of biopsy-
proven glomerulonephritis in Australia. Nephrol Dial Transplant
16:1364–1367, 2001
6. HEAF J, OKKEGAARD H, LARSEN S: The epidemiology and prognosis
of glomerulonephritis in Denmark 1985–1997. Nephrol Dial Trans-
plant 14:1889–1897, 1999
7. RESEARCH GROUP ON PROGRESSIVE CHRONIC RENAL DISEASE: Nation-
wide and long-term survey of primary glomerulonephritis in Japan
as observed in 1,850 biopsied cases. Nephron 82:205–213, 1999
8. TIEBOSCH AT, WOLTERS J, FREDERIK PF, et al: Epidemiology of idio-
pathic glomerular disease: A prospective study. Kidney Int 32:112–
116, 1987
9. CHOI IJ, JEONG HJ, HAN DS, et al: An analysis of 4.514 cases of renal
biopsy in Korea. Yonsei Med J 42:247–254, 2001
10. RIVERA F, LO´PEZ-GO´MEZ JM, PE´REZ-GARCı´A R, IN REPRESENTATION
OF THE SPANISH REGISTRY OF GLOMERULONEPHRITIS: Frequency of
renal pathology in Spain for 1994–1999. Nephrol Dial Transplant
17:1594–1602, 2002
11. COUSER WG: Rapidly progressive glomerulonephritis: Classifica-
tion, pathogenetic mechanisms, and therapy. Am J Kidney Dis
11:449–464, 1988
12. WOO KT, CHIANG GS, PALL A, et al: The changing pattern of
glomerulonephritis in Singapore over the past two decades. Clin
Nephrol 52:96–102, 1999
13. HAAS M, MEEHAN SM, KARRISON TG, SPARGO BH: Changing eti-
ologies of unexplained adult nephrotic syndrome: A comparison of
renal biopsy findings from 1976–1979 and 1995–1997. Am J Kidney
Dis 30:621–631, 1997
14. KORBET SM, GENCHI RM, BOROK RZ, SCHWARTZ MM: The racial
prevalence of glomerular lesions in nephrotic adults. Am J Kidney
Dis 27:647–651, 1996
15. BRADEN GL, MULHERN JG, O’SHEA MH, et al: Changing incidence
of glomerular diseases in adults. Am J Kidney Dis 35:878–883, 2000
16. HISANO S, HUEDA K: Asymptomatic hematuria and proteinuria: Re-
nal pathology and clinical outcome in 54 children. Pediatr Nephrol
5:578–581, 1991
17. HAAS M, SPARGO BH, WIT EJC, MEEHAN SM: Etiologies and out-
come of acute renal insufficiency in older adults: A renal biopsy
study of 259 cases. Am J Kidney Dis 35:433–447, 2000
18. FUIANO G, MAZZA G, COMI N, et al: Current indications for renal
biopsy: A questionnaire based survey. Am J Kidney Dis 35:448–457,
2000
19. YAHYA TM, PINGLE A, BOOBES Y, PINGLE S: Analysis of 490 kid-
ney biopsies: Data from the United Arab Emirates renal diseases
registry. J Nephrol 11:148–150, 1997
20. CAMERON JS: Nephrotic syndrome in the elderly. Semin Nephrol
16:319–329, 1997
21. DAVISON AM: Renal disease in the elderly. Contrib Nephrol
124:126–137, 1998
22. COLOMBO V, CONFALONIERI R, MINOLA E, et al: Renal biopsies in the
elderly. Contrib Nephrol 105:102–106, 1993
23. MODESTO-SEGONDS A, AH-SOUNE MF, DURAND D, SUC JM: Renal
biopsy in the elderly. Am J Nephrol 13:27–34, 1993
24. MOORTHY AV, ZIMMERMAN SW: Renal disease in the elderly: Clin-
icopathologic analysis of renal disease in 115 elderly patients. Clin
Nephrol 14:223–229, 1980
25. VENDEMIA F, GESUALDO L, SCHENA FP, D’AMICO G: Epidemiology
of primary glomerulonephritis in the elderly. Report from the Italian
Registry of Renal Biopsy. J Nephrol 14:340–352, 2001
26. STUDY GROUP OF THE SPANISH SOCIETY OF NEPHROLOGY: Progressively
decreasing incidence of membranoproliferative glomerulonephritis
in Spanish adult population. Nephron 52:370–371, 1989
